Skip to main content

Table 2 Association of miR-15b-3p Expression in GC with Different Clinicopathological Features

From: Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer

Variables

Exo-miR-15b-3p expression

P-value

Low(n = 54)

High(n = 54)

Age, years

  

0.425

 <60

22(40.7%)

18(33.3%)

 

 ≥ 60

32(59.3%)

36(66.7%)

 

Gender

  

0.661

 Male

41(75.9%)

39(72.2%)

 

 Female

13(24.1%)

15(27.8%)

 

Smoking

  

0.311

 Yes

16(29.6%)

21(38.9%)

 

 No

38(70.4%)

33(61.1%)

 

Alcohol abuse

  

0.024*

 Yes

8(14.8%)

18(33.3%)

 

 No

46(85.2%)

36(66.7%)

 

Family history of cancer

  

0.206

 Yes

7(13.0%)

12(22.2%)

 

 No

47(87.0%)

42(77.8%)

 

Size, cm

  

0.020*

 <3.5

30(55.6%)

18(33.3%)

 

 ≥ 3.5

24(44.4%)

36(66.7%)

 

Location

  

0.267

 Cardia

16(29.6%)

11(20.4%)

 

 Non-cardia

38(70.4%)

43(79.6%)

 

Lauren’s classification

  

0.101

 Intestinal type

22(40.7%)

14(25.9%)

 

 Diffuse type

20(37.0%)

31(57.4%)

 

 Mixed type

12(22.2%)

9(16.7%)

 

Histological grade

  

0.011*

 Well differentiated

22(40.7%)

10(18.5%)

 

 Poor differentiated

32(59.3%)

44(81.5%)

 

Invasion depth

  

0.176

 T1/2

28(51.9%)

21(38.9%)

 

 T3/4

26(48.1%)

33(61.1%)

 

Tumor stage

  

0.002*

 I,II

38(70.4%)

22(40.7%)

 

 III,IV

16(29.6%)

32(59.3%)

 

Lymphovascular invasion

  

0.001*

 Negative

37(68.5%)

20(37.0%)

 

 Positive

17(31.5%)

34(63.0%)

 
  1. *P < 0.05